PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of headpainSpringerOpen.comSubmit OnlineRegisterThis journalThis article
 
J Headache Pain. Aug 2008; 9(4): 221–224.
Published online Jul 2, 2008. doi:  10.1007/s10194-008-0047-5
PMCID: PMC3451944
Low urinary 6-sulphatoxymelatonin concentrations in acute migraine
Marcelo Rodrigues Masruha,1,2 Domingos Sávio de Souza Vieira,2 Thais Soares Cianciarullo Minett,1 José Cipolla-Neto,3 Eliova Zukerman,2 Luiz Celso Pereira Vilanova,1 and Mario Fernando Prieto Perescorresponding author1,2
1Department of Neurology and Neurosurgery, Federal University of São Paulo, São Paulo, Brazil
2Instituto Israelita de Ensino e Pesquisa Albert Einstein, Hospital Israelita Albert Einstein, Av. Albert Einstein, 627/701, Morumbi, São Paulo, 05651-901 Brazil
3Department of Physiology and Biophysics, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
Mario Fernando Prieto Peres, Phone: +55-11-37470456, marioperes/at/yahoo.com.
corresponding authorCorresponding author.
Received April 27, 2008; Accepted June 3, 2008.
Abstract
Substantial evidence points to melatonin as playing a role in the regulation of circadian rhythms, sleep, and headache disorders. The objective of the study was to assess 6-sulphatoxymelatonin (aMT6s) levels in a large consecutive series of patients with migraine, comparing with controls. A total of 220 subjects were evaluated—146 had migraine and 74 were control subjects. Urinary samples were collected into the same plastic container since 8:00 p.m. to 8:00 a.m. of the next day (12-h period) and aMT6s was measured with quantitative ELISA technique. Among patients with migraine, 53% presented pain on the day of the urine samples collection. Their urinary aMT6s concentration was significantly lower than in the urine of patients without pain [14.0 ± 7.3 vs. 49.4 ± 19.0; t(143) = −15.1; 95% CI = −40.0 to −30.8; P < 0.001]. There was no significant difference in the aMT6s concentration of patients with migraine without pain on the day of their urine samples collection and controls [49.4 ± 19.0 vs. 42.5 ± 27.9; t(140) = 1.7; 95% CI = −1.2 to 14.8; P = 0.094]. To our knowledge, this is the first study to demonstrate reduction in melatonin levels during attacks in episodic and chronic migraine.
Full Text
The Full Text of this article is available as a PDF (159K).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
1. Blau JN. Migraine pathogenesis: the neural hypothesis reexamined. J Neurol Neurosurg Psychiatry. 1984;47(5):437–442. [PMC free article] [PubMed]
2. Bruyn GW. The biochemistry of migraine. Headache. 1980;20(5):235–246. doi: 10.1111/j.1526-4610.1980.hed2005235.x. [PubMed] [Cross Ref]
3. Silberstein SD. Advances in understanding the pathophysiology of headache. Neurology. 1992;42:6–10. [PubMed]
4. Zurak N. Role of the suprachiasmatic nucleus in the pathogenesis of migraine attacks. Cephalalgia. 1997;17(7):723–728. doi: 10.1046/j.1468-2982.1997.1707723.x. [PubMed] [Cross Ref]
5. Rao NS, Pearce J. Hypothalamic–pituitary–adrenal axis studies in migraine with special reference to insulin sensitivity. Brain. 1971;94(2):289–298. doi: 10.1093/brain/94.2.289. [PubMed] [Cross Ref]
6. Kaube H, Goadsby PJ. Anti-migraine compounds fail to modulate the propagation of cortical spreading depression in the cat. Eur Neurol. 1994;34(1):30–35. doi: 10.1159/000117004. [PubMed] [Cross Ref]
7. Wever RA. The circadian system of man: results of experiments under temporal isolation. Berlin: Springer; 1979.
8. Dodick DW, et al. Clinical, anatomical, and physiologic relationship between sleep and headache. Headache. 2003;43(3):282–292. doi: 10.1046/j.1526-4610.2003.03055.x. [PubMed] [Cross Ref]
9. Bojkowski CJ, Arendt J. Factors influencing urinary 6-sulphatoxymelatonin, a major melatonin metabolite, in normal human subjects. Clin Endocrinol (Oxf) 1990;33(4):435–444. doi: 10.1111/j.1365-2265.1990.tb03882.x. [PubMed] [Cross Ref]
10. Peres MF. Melatonin, the pineal gland and their implications for headache disorders. Cephalalgia. 2005;25(6):403–411. doi: 10.1111/j.1468-2982.2005.00889.x. [PubMed] [Cross Ref]
11. Markey SP, et al. The correlation between human plasma melatonin levels and urinary 6-hydroxymelatonin excretion. Clin Chim Acta. 1985;150(3):221–225. doi: 10.1016/0009-8981(85)90247-5. [PubMed] [Cross Ref]
12. Brzezinski A. Melatonin in humans. N Engl J Med. 1997;336(3):186–195. doi: 10.1056/NEJM199701163360306. [PubMed] [Cross Ref]
13. Claustrat B, et al. Nocturnal plasma melatonin levels in migraine: a preliminary report. Headache. 1989;29(4):242–245. doi: 10.1111/j.1526-4610.1989.hed22904242.x. [PubMed] [Cross Ref]
14. Brun J, et al. Nocturnal melatonin excretion is decreased in patients with migraine without aura attacks associated with menses. Cephalalgia. 1995;15(2):136–139. doi: 10.1046/j.1468-2982.1995.015002136.x. [PubMed] [Cross Ref]
15. Murialdo G, et al. Urinary melatonin excretion throughout the ovarian cycle in menstrually related migraine. Cephalalgia. 1994;14(3):205–209. doi: 10.1046/j.1468-2982.1994.014003205.x. [PubMed] [Cross Ref]
16. Claustrat B, et al. Melatonin secretion is supersensitive to light in migraine. Cephalalgia. 2004;24(2):128–133. doi: 10.1111/j.1468-2982.2004.00645.x. [PubMed] [Cross Ref]
17. Salvesen R, Bekkelund SI. Migraine, as compared to other headaches, is worse during midnight-sun summer than during polar night. A questionnaire study in an Arctic population. Headache. 2000;40(10):824–829. doi: 10.1046/j.1526-4610.2000.00149.x. [PubMed] [Cross Ref]
18. The International Classification of Headache Disorders (2004) 2nd edn. Cephalalgia 24(suppl 1):9–160.
19. Bojkowski CJ, Arendt J. Annual changes in 6-sulphatoxymelatonin excretion in man. Acta Endocrinol (Copenh) 1988;117(4):470–476. [PubMed]
20. Peres MF, et al. Hypothalamic involvement in chronic migraine. J Neurol Neurosurg Psychiatry. 2001;71(6):747–751. doi: 10.1136/jnnp.71.6.747. [PMC free article] [PubMed] [Cross Ref]
Articles from The Journal of Headache and Pain are provided here courtesy of
Springer